DIO, 05 Jun 2019 The treatment of migraine is impeded by several difficulties, among which insufficient headache relief, side effects, and risk…
Neurology Times, 05 Jun 2019 Acute treatment for migraine is likely to improve with 2 novel classes of drugs, 5-HT1F receptor agonists (lasmiditan) and…